Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay G Bhoj

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Immunological Reviews|August 5, 2021
On the road to eliminating long-lived plasma cells-"are we there yet?"Caroline Markmann, Vijay G Bhoj
Molecular Therapy. Methods & Clinical Development|March 20, 2018
The Pharmacology of T Cell TherapiesMichael C Milone, Vijay G Bhoj
Current Atherosclerosis Reports|May 26, 2015
Lipoprotein apheresisVijay G Bhoj, Bruce S Sachais
Nature|March 28, 2009
Ubiquitylation in innate and adaptive immunityVijay G Bhoj, Zhijian J Chen
Cell|August 30, 2008
Linking retroelements to autoimmunityVijay G Bhoj, Zhijian J Chen
Cellular Immunology|November 6, 2020
Conventional T cell therapies pave the way for novel Treg therapeuticsLucy Z Li, Zheng Zhang, Vijay G Bhoj
Discovery Medicine|May 28, 2016
Novel gene and cellular therapy approaches for treating HIVVijay G Bhoj, Suzanne R Thibodeaux, Bruce L Levine
Journal of Immunology (Baltimore, Md. : 1950)|November 7, 2022
Therapeutic Opportunities for Immunoreceptor-Engineered T Cell Therapy for Modulation of AlloimmunityKavitha Muralidharan, Divyansh Agarwal, Ali Naji, et al.
Human Immunology|November 26, 2024
Cars pick up another passenger: Organ transplantationGeorgia F Papadaki, Yang Li, Dimitri S Monos, et al.
Advances in Pharmacology (San Diego, Calif.)|July 6, 2026
Fundamentals of engineered T cell therapies: From basic design to bells and whistlesJanna C Minehart, Eric W Cross, Praise S Oo, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Immunological Reviews|August 5, 2021
On the road to eliminating long-lived plasma cells-"are we there yet?"Caroline Markmann, Vijay G Bhoj
Molecular Therapy. Methods & Clinical Development|March 20, 2018
The Pharmacology of T Cell TherapiesMichael C Milone, Vijay G Bhoj
Current Atherosclerosis Reports|May 26, 2015
Lipoprotein apheresisVijay G Bhoj, Bruce S Sachais
Nature|March 28, 2009
Ubiquitylation in innate and adaptive immunityVijay G Bhoj, Zhijian J Chen
Cell|August 30, 2008
Linking retroelements to autoimmunityVijay G Bhoj, Zhijian J Chen
Cellular Immunology|November 6, 2020
Conventional T cell therapies pave the way for novel Treg therapeuticsLucy Z Li, Zheng Zhang, Vijay G Bhoj
Discovery Medicine|May 28, 2016
Novel gene and cellular therapy approaches for treating HIVVijay G Bhoj, Suzanne R Thibodeaux, Bruce L Levine
Journal of Immunology (Baltimore, Md. : 1950)|November 7, 2022
Therapeutic Opportunities for Immunoreceptor-Engineered T Cell Therapy for Modulation of AlloimmunityKavitha Muralidharan, Divyansh Agarwal, Ali Naji, et al.
Human Immunology|November 26, 2024
Cars pick up another passenger: Organ transplantationGeorgia F Papadaki, Yang Li, Dimitri S Monos, et al.
Advances in Pharmacology (San Diego, Calif.)|July 6, 2026
Fundamentals of engineered T cell therapies: From basic design to bells and whistlesJanna C Minehart, Eric W Cross, Praise S Oo, et al.
Pageof 4